Bunge Global BG
- Market cap
- $19.8B
- PE
- 20.0×
- 10y median 10.5×
- Forward PE
- 9.8×
- 10y median 12.5×
- Price to sales
- 0.2×
- EV/EBIT
- 16.3×
- Revenue, 12 months
- $91.8B
- +81% on a year ago
- Net margin
- 1.1%
- Free cash flow yield
- −3.6%
Bunge Global trades at 20.0× trailing earnings, pricier than 69% of the last ten years. Revenue was $91.8B over the last twelve months, up 81% on a year earlier with a 1% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $14.2B−15% | $14.9B−10% | $13.4B−13% | $13.2B−12% | $12.9B−9% | $13.5B−9% | $11.6B−13% | $12.8B−4% | $22.2B+72% | $23.8B+76% | $21.9B+88% | $24B+88% | |
| Cost of revenue | $13.2B−17% | $13.7B−14% | $12.5B−11% | $12.6B−8% | $12.1B−8% | $12.5B−9% | $11B−12% | $12B−4% | $21.1B+74% | $22.8B+83% | $21.1B+91% | $22.4B+86% |
| Gross profit | $1B+18% | $1.3B+53% | $876M−26% | $664M−51% | $772M−26% | $1.1B−14% | $597M−32% | $738M+11% | $1.1B+38% | $1B−7% | $766M+28% | $1.7B+128% |
| SG&A | $447M+33% | $495M+27% | $439M+24% | $449M+7% | $437M−2% | $451M−9% | $380M−13% | $418M−7% | $678M+55% | $637M+41% | $531M+40% | $606M+45% |
| $637M+10% | $816M+86% | $445M−48% | $169M−83% | $315M−51% | $650M−20% | $222M−50% | $323M+91% | $393M+25% | $384M−41% | $238M+7% | $1.1B+236% | |
| Interest expense | $133M+29% | $142M+46% | $108M−4% | $123M−5% | $127M−5% | $113M−20% | $104M−4% | $106M−14% | $202M+59% | $216M+91% | $181M+74% | $197M+86% |
| Pre-tax income | $503M+1% | $879M+74% | $369M−56% | $103M−88% | $322M−36% | $730M−17% | $284M−23% | $494M+380% | $270M−16% | $86M−88% | $61M−79% | $943M+91% |
| $114M+1% | $219M+67% | $117M−36% | $30M−85% | $89M−22% | $100M−54% | $80M−32% | $124M+313% | $86M−3% | −$2M | −$14M | $236M+90% | |
| Net income | $373M−2% | $616M+83% | $244M−61% | $70M−89% | $221M−41% | $602M−2% | $201M−18% | $354M+406% | $166M−25% | $95M−84% | $68M−66% | $678M+92% |
| $2.47−1% | $4.18+89% | $1.68−60% | $0.48−88% | $1.56−37% | $4.36+4% | $1.48−12% | $2.61+444% | $0.84−46% | $0.49−89% | $0.35−76% | $3.47+33% | |
| 151.2M−1% | 147.5M−3% | 145.4M−5% | 143.2M−6% | 142.1M−6% | 138.2M−6% | 135.4M−7% | 135.6M−5% | 198.5M+40% | 195.4M+41% | 195.7M+45% | 195.3M+44% |
Operating income: 73 periods, Q2 FY08 to Q2 FY26: not printed by the filing, worked out from its own lines.
EPS, diluted: Q4 FY09: quarter's net income to common over its shares, to the cent.
Diluted shares: Q2 FY08 and Q3 FY08: not printed by the filing, worked out from its own lines. 4 periods, Q4 FY09 to Q4 FY19: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. 6 periods, Q4 FY20 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Estimates
Next earnings report: .
| Quarter | Revenue | Range | EPS | Range | Analysts |
|---|---|---|---|---|---|
| Q3 FY26 | $23.3B | $22.4B to $24.2B | $2.41 | $2.33 to $2.48 | 4 |
| Q4 FY26 | $23.7B | $23.6B to $23.8B | $3.25 | $3.20 to $3.30 | 4 |
| Q1 FY27 | $23.3B | $22.4B to $23.8B | $2.50 | $2.36 to $2.56 | 1 |
| Q2 FY27 | $25B | $24B to $25.5B | $2.44 | $2.31 to $2.50 | 1 |
| Q3 FY27 | $23.9B | $23B to $24.4B | $2.75 | $2.60 to $2.81 | 1 |
| Q4 FY27 | $24.7B | $23.7B to $25.2B | $3.39 | $3.21 to $3.47 | 1 |
| Q1 FY28 | $25.2B | $24.2B to $25.7B | $2.63 | $2.49 to $2.69 | 2 |
| Q2 FY28 | $26.1B | $25B to $26.6B | $2.57 | $2.43 to $2.63 | 2 |
Peers
Companies in Agricultural Farm Products nearest Bunge Global's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| BGBunge Global | $19.8B | 20.0× | 10.5× | 9.8× | 0.2× | +81% | 1.1% |
| TSNTyson Foods | $19.9B | 35.0× | 12.8× | n/m | 0.4× | +3% | 1.0% |
| ADMArcher-Daniels-Midland | $38.6B | 22.0× | 15.4× | 13.5× | 0.5× | −1% | 2.2% |
| DARDarling Ingredients | $8.9B | 15.2× | 20.6× | n/m | 1.4× | +15% | 9.1% |
| PPCPilgrims Pride | $6.7B | 12.2× | 12.8× | n/m | 0.4× | +1% | 3.0% |
| Peer median | $14.4B | 18.6× | 14.1× | 13.5× | 0.4× | +2% | 2.6% |
Investors who own it
Investors we follow who held Bunge Global at the end of Jun 30, 2026, from their 13F filings.
- Lee AinslieMaverick Capital0.0% of portfolioadded
More on Bunge Global
Each number over time
- PE ratio
- Forward PE
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Dividend yield
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #2of 129Consumer staples stocks with the fastest revenue growth
- #1of 26Consumer staples stocks with the lowest forward PE
- #1of 16Consumer staples stocks with the lowest PEG ratio
Its groups
About
- Industry
- Agricultural Farm Products
- Sector
- Consumer Defensive
Valuation data, not investment advice. Prices as of .